Home Arcellx

Arcellx

acquired
IPO Delisting
Developer of Immunocyte Therapy

Basic Information

Arcellx is a privately held biopharmaceutical company located in Montgomery County, Maryland. The Arcellx team is committed to providing patients with superior immune cell therapies through scientific innovation, accelerated development, and responsible patient care. Although the company's initial clinical focus is on cancer treatment, it remains dedicated to expanding Antigen Receptor Complex T-cell (ARC-T) therapy to a broad range of human diseases.
Arcellx, Inc.
Maryland,United States of America
51~100 people
January 01, 2015
info@arcellx.com